Document text
Principal Investigator: YASUKO IWAKIRI
Organization: YALE UNIVERSITY
Fiscal Year: 2023
Award: $211,584
Funding agency: National Institute on Alcohol Abuse and Alcoholism
SUMMARY
A subset of patients with alcohol-associated liver disease (ALD) develop severe alcoholic hepatitis
(AH), carrying a very poor prognosis. Control of inflammation is a key to the treatment of AH. Hepatic
lymphatics are highly involved in the regulation of the inflammatory response by discharging extravasated
fluids, inflammatory mediators, antigens, and antigen-presenting cells to lymph nodes outside the liver.
However, how the hepatic lymphatic system is involved in the development of ALD remains largely unknown.
The goal of this exploratory study is to advance our understanding of hepatic lymphatics in the progression of
AH and explore whether increasing lymphatic vessels (LVs) and lymphatic drainage can be a novel therapeutic
strategy for AH.
Given that lymphatics generally help to reduce tissue inflammation, we hypothesize that chronic
alcohol consumption may impair hepatic lymphatic endothelial cell (EC) function and lymphatic drainage,
facilitating the progression to AH. Contrarily, enhancing lymphangiogenesis (new LV formation) via
overexpression of vascular endothelial growth factor (VEGF)-C, the most potent lymphangiogenic factor, may
ameliorate AH. To test these hypotheses, we propose the following two Aims:
Aim 1. Determine the role of the hepatic lymphatic system in AH.
Aim 2. Explore the potential of the VEGF-C mRNA LNP (lipid nanoparticle) technology for the treatment of
severe AH.
This study will explore an important, but poorly understood subject, liver lymphatics in ALD, addressing
the effect of alcohol on hepatic lymphatic functions and its implications in the development of AH. Results from
the two Aims above will provide the foundation for many future studies to advance our understanding of the
lymphatic system in liver disease in general and AH in particular, including a study addressing the molecular
mechanism of lymphatic impairment by alcohol as well as a study aiming at clinical use of VEGF-C mRNA-LNP
for the treatment of AH.
Terms: <Absolute ethanol><Address><Alcohol Chemical Class><Alcohol Drinking><Alcohol abuse><Alcohol associated hepatitis><Alcohol consumption><Alcohol hepatitis><Alcohol induced hepatitis><Alcohol related hepatitis><Alcoholic Hepatitis><Alcoholic Liver Diseases><Alcohols><Antigen-Presenting Cells><Antigens><Bile Duct Obstruction><Biliary Stasis><Body Tissues><California><Cell Function><Cell Process><Cell physiology><Cell surface><Cellular Function><Cellular Physiology><Cellular Process><Cholestasis><Chronic><Cirrhosis><Clinical><Collaborations><Consumption><Development><Diet><ETOH><Encapsulated><Endothelial Cells><EtOH abuse><EtOH drinking><EtOH use><Ethanol><Ethanol-induced hepatitis><Ethyl Alcohol><Exhibits><Extravasation><FLT4 Ligand><FLT4-L><Foundations><Future><Gene Expression><Goals><Grain Alcohol><Hepatic><Hepatic Cells><Hepatic Disorder><Hepatic Parenchymal Cell><Hepatocyte><Hybrids><IL-7><IL-7 Gene><IL7><IL7 Protein><IL7 gene><Impairment><Inflammation><Inflammation Mediators><Inflammatory Response><Infusion><Infusion procedures><Injury to Liver><Interleukin 7 Precursor><Interleukin 7 Precursor Gene><Interleukin-7><Interleukin-7 Gene><Leakage><Liquid substance><Liver><Liver Cells><Liver diseases><Lymph Node Reticuloendothelial System><Lymph System><Lymph node proper><Lymphangiogeneses><Lymphangiogenesis><Lymphatic><Lymphatic Endothelial Cells><Lymphatic Network><Lymphatic System><Lymphatic System Reticuloendothelial System><Lymphatic function><Lymphatic nodes><Lymphopoietin-1><Mesothelial Cell><Messenger RNA><Methylcarbinol><Mice><Mice Mammals><Modeling><Molecular><Murine><Mus><Pathologic><Patients><Pennsylvania><Phenotype><Population><Prognosis><Protocol><Protocols documentation><Regulation><Reporter><Role><Spillage><Structure><Subcellular Process><Technology><Testing><Tissues><Universities><VEGF-C><Vascular Endothelial Growth Factor C><Vascular Endothelial Growth Factor Related Protein><accessory cell><alcohol co-abuse><alcohol effect><alcohol induced hepatic injury><alcohol induced liver disorder><alcohol induced liver injury><alcohol ingestion><alcohol intake><alcohol problem><alcohol product use><alcohol related liver disease><alcohol use><alcohol-associated liver disease><alcohol-induced hepatic dysfunction><alcohol-induced liver disease><alcohol-induced liver dysfunction><alcohol-mediated liver dysfunction><alcohol-mediated liver injury><alcohol-related liver disease><alcoholic beverage consumption><alcoholic drink intake><alcoholic liver injury><bile obstruction><bile occlusion><cholangiocyte><cholestatic diseases><cholestatic disorder><cholestatic liver disease><cholestatic liver disorder><cholestatic syndromes><chronic EtOH drinking><chronic alcohol consumption><chronic alcohol drinking><chronic alcohol ingestion><chronic alcohol use><chronic ethanol consumption><chronic ethanol drinking><chronic ethanol ingestion><cirrhotic><clinical relevance><clinically relevant><developmental><diets><ethanol abuse><ethanol consumption><ethanol drinking><ethanol effect><ethanol induced hepatic injury><ethanol induced liver disorder><ethanol induced liver injury><ethanol ingestion><ethanol intake><ethanol liver disease><ethanol product use><ethanol use><ethanol-induced hepatic dysfunction><ethanol-induced liver disease><ethanol-induced liver dysfunction><ethanol-mediated liver dysfunction><ethanol-mediated liver injury><experiment><experimental research><experimental study><experiments><feeding><fluid><gain of function><hazardous alcohol use><hepatic body system><hepatic damage><hepatic disease><hepatic inflammation><hepatic injury><hepatic organ system><hepatopathy><immunogen><in vivo><inflamed liver><inflammatory mediator><infusions><lipid based nanoparticle><lipid nanoparticle><liquid><liver damage><liver disorder><liver inflammation><liver injury><loss of function><lymph channel><lymph gland><lymph nodes><lymph vessel><lymphatic channel><lymphatic drainage><lymphatic dysfunction><lymphatic impairment><lymphatic vessel><lymphnodes><mRNA><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><novel><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><overexpress><overexpression><patient subgroups><patient subpopulations><patient subsets><patient subtypes><problem alcohol use><problem drinking><problematic alcohol consumption><problematic alcohol use><scRNA-seq><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><transcriptomics><western diet><western-style diet><western-type diet>